https://tanepon.com/ Evidence-based insight on pain therapeutics and trials en Thu, 22 Oct 2026 08:05:45 GMT https://tanepon.com/five-non-opioid-painkillers-in-development/ https://tanepon.com/five-non-opioid-painkillers-in-development/ From sodium channel blockers to next-generation NGF antibodies, a wave of non-opioid analgesics is moving through late-stage clinical trials. Here's a look at five candidates that could shape the future of pain care in the United States. Tanepon Clinical Review Drug Pipeline Thu, 22 Oct 2026 08:05:45 GMT https://tanepon.com/ngf-inhibitor-regulatory-rejection-tanezumab-review/ https://tanepon.com/ngf-inhibitor-regulatory-rejection-tanezumab-review/ Tanezumab was positioned as a landmark non-opioid therapy for chronic osteoarthritis pain, yet it never reached American patients. We examine the clinical evidence, the joint-safety signals, and the regulatory reasoning behind two complete response letters. Tanepon Clinical Review Regulatory Analysis Thu, 22 Oct 2026 08:05:45 GMT